Correlation Between Medesis Pharma and Euronext

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medesis Pharma and Euronext at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medesis Pharma and Euronext into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medesis Pharma SA and Euronext NV, you can compare the effects of market volatilities on Medesis Pharma and Euronext and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medesis Pharma with a short position of Euronext. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medesis Pharma and Euronext.

Diversification Opportunities for Medesis Pharma and Euronext

-0.64
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Medesis and Euronext is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Medesis Pharma SA and Euronext NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Euronext NV and Medesis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medesis Pharma SA are associated (or correlated) with Euronext. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Euronext NV has no effect on the direction of Medesis Pharma i.e., Medesis Pharma and Euronext go up and down completely randomly.

Pair Corralation between Medesis Pharma and Euronext

Assuming the 90 days trading horizon Medesis Pharma SA is expected to generate 2.98 times more return on investment than Euronext. However, Medesis Pharma is 2.98 times more volatile than Euronext NV. It trades about 0.05 of its potential returns per unit of risk. Euronext NV is currently generating about 0.04 per unit of risk. If you would invest  41.00  in Medesis Pharma SA on August 27, 2024 and sell it today you would earn a total of  1.00  from holding Medesis Pharma SA or generate 2.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Medesis Pharma SA  vs.  Euronext NV

 Performance 
       Timeline  
Medesis Pharma SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medesis Pharma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Euronext NV 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Euronext NV are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Euronext may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Medesis Pharma and Euronext Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medesis Pharma and Euronext

The main advantage of trading using opposite Medesis Pharma and Euronext positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medesis Pharma position performs unexpectedly, Euronext can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Euronext will offset losses from the drop in Euronext's long position.
The idea behind Medesis Pharma SA and Euronext NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Transaction History
View history of all your transactions and understand their impact on performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal